These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Government officials urge nuclear physicians to be more active in political process. Kotz D J Nucl Med; 1999 May; 40(5):13N, 15N, 31N. PubMed ID: 10319737 [No Abstract] [Full Text] [Related]
46. Nuclear medicine. Davis S NCSL Legisbrief; 2000 Oct; 8(41):1-2. PubMed ID: 11850887 [No Abstract] [Full Text] [Related]
47. [Preparation and control of radiopharmaceuticals from generator-produced radioisotopes in medical radioisotope laboratories]. Raban IP Cas Lek Cesk; 1971 Jan; 110(3):74. PubMed ID: 5540138 [No Abstract] [Full Text] [Related]
48. Potential impact of releases from a new molybdenum-99 production facility on regional measurements of airborne xenon isotopes. Bowyer TW; Eslinger PW; Cameron IM; Friese JI; Hayes JC; Metz LA; Miley HS J Environ Radioact; 2014 Mar; 129():43-7. PubMed ID: 24365483 [TBL] [Abstract][Full Text] [Related]
49. Reduce, reuse and recycle: a green solution to Canada's medical isotope shortage. Galea R; Ross C; Wells RG Appl Radiat Isot; 2014 May; 87():148-51. PubMed ID: 24332878 [TBL] [Abstract][Full Text] [Related]
50. Ethical issues in radioisotope shortages: rationing and priority setting. Rosenthal MS J Nucl Med Technol; 2010 Sep; 38(3):117-20. PubMed ID: 20807853 [TBL] [Abstract][Full Text] [Related]
51. PRELIMINARY PHYSIOLOGICAL STUDIES OF MOLYBDENUM (MO99) IN LIVER SCANNING. SORENSEN LB; ARCHAMBAULT M Radiology; 1964 Feb; 82():318-9. PubMed ID: 14115318 [No Abstract] [Full Text] [Related]
52. Cysteine rhenium colloid: a novel radiocolloid for identifying sentinel lymph nodes in breast cancer surgery. Kidane B; Zabel PL; Gupta V; Whiston C; Wright F; Brackstone M Clin Breast Cancer; 2015 Feb; 15(1):e41-5. PubMed ID: 25220300 [TBL] [Abstract][Full Text] [Related]
53. Proliferation dangers associated with nuclear medicine: getting weapons-grade uranium out of radiopharmaceutical production. Williams B; Ruff TA Med Confl Surviv; 2007; 23(4):267-81. PubMed ID: 17987979 [TBL] [Abstract][Full Text] [Related]
55. Radiation dose from radiopharmaceuticals contaminated with molybdenum-99. Shearer DR; Pezzullo JC; Moore MM; Coleman P; Frater SI J Nucl Med; 1988 May; 29(5):695-700. PubMed ID: 2836569 [TBL] [Abstract][Full Text] [Related]
56. Radiopharmaceuticals and their use in the current practice of nuclear medicine. Fejka RM Lippincotts Prim Care Pract; 1999; 3(6):531-45. PubMed ID: 10889704 [No Abstract] [Full Text] [Related]
57. SNM takes international spotlight during global isotope crisis. Pappas V J Nucl Med; 2009 Aug; 50(8):29N, 34N. PubMed ID: 19652214 [No Abstract] [Full Text] [Related]
58. Future of nuclear medicine, part 3: assessment of the U.S. therapeutic radiopharmaceuticals market (2001-2020). J Nucl Med; 1998 Jul; 39(7):14N, 17N-18N, 20N-22N, 25N, 27N. PubMed ID: 9669377 [No Abstract] [Full Text] [Related]
59. [The role of Japan Radioisotope Association in nuclear medicine]. Nagai T Kaku Igaku; 1994 Jan; 31(1):85-90. PubMed ID: 8309114 [TBL] [Abstract][Full Text] [Related]